key: cord-0936413-z6cjuaaw
authors: Pujadas, Elisabet; Beaumont, Michael; Shah, Hardik; Schrode, Nadine; Francoeur, Nancy; Shroff, Sanjana; Bryce, Clare; Grimes, Zachary; Gregory, Jill; Donnelly, Ryan; Fowkes, Mary E.; Beaumont, Kristin G.; Sebra, Robert; Cordon-Cardo, Carlos
title: Molecular Profiling of COVID-19 Autopsies Uncovers Novel Disease Mechanisms
date: 2021-09-08
journal: Am J Pathol
DOI: 10.1016/j.ajpath.2021.08.009
sha: f3f2d118e3da82a87cdd896d9944ccf3d75d7d60
doc_id: 936413
cord_uid: z6cjuaaw

Current understanding of COVID-19 pathophysiology is limited by disease heterogeneity, complexity, and a paucity of studies assessing patient tissues with advanced molecular tools. Rapid autopsy tissues were evaluated using multi-scale RNASeq methods (bulk, single-nuclei, and spatial RNASeq next-generation sequencing) to provide unprecedented molecular resolution of COVID-19 induced damage. Comparison of infected/uninfected tissues revealed four major regulatory pathways. Effectors within these pathways could constitute novel therapeutic targets, including the complement receptor C3AR1, calcitonin receptor like receptor or decorin. Single-nuclei RNA sequencing of olfactory bulb and prefrontal cortex highlighted remarkable diversity of coronavirus receptors. ACE2 was rarely expressed, while BSG showed diffuse expression, and ANPEP was associated with vascular/mesenchymal cell types. Comparison of lung and lymph node tissues from patients with different symptomatology (one died after a month-long hospitalization with multi-organ involvement, the other after a few days of respiratory symptoms) with digital spatial profiling resulted in distinct molecular phenotypes. Evaluation of COVID-19 rapid autopsy tissues with advanced molecular techniques can identify pathways and effectors, map diverse receptors at the single-cell level, and help dissect differences driving diverging clinical courses among individual patients. Extension of this approach to larger datasets will substantially advance the understanding of the mechanisms behind COVID-19 pathophysiology.

Concerted research efforts are quickly advancing the understanding of COVID-19 pathophysiology, highlighting pathways that influence uncontrolled cytokine release and vascular injury 1,2,3 , and suggesting distinct disease stages 4 . Studies directly evaluating patient tissues 5,6,7 , however, often lack the resolution afforded by interrogation with advanced molecular methods.

Highly dimensional, patient-specific datasets can be generated through multi-scale, nextgeneration sequencing of well-preserved rapid autopsy tissues. Bulk sequencing yields high-read depth profiling, while single-nuclei methods and spatial profiling can interrogate distinct cellular subpopulations. Mining of such datasets can facilitate novel hypothesis generation, thus advancing the molecular understanding of SARS-CoV-2 infection and COVID-19 disease mechanisms.

Clinical information and tissue collection: Rapid autopsies (post-mortem interval of 6 hours) were performed on two decedents (Patient 1 and Patient 2) with appropriate consent and following COVID-19 safety protocols as part of the Mount Sinai COVID-19 autopsy study cohort 8 . Patient 1 was a male in his 60s with a complex medical history including well-controlled HIV, organ transplantation and head and neck squamous cell carcinoma in clinical remission (with no evidence of residual disease at autopsy) who was admitted for treatment of COVID-19 at Mount Sinai Hospital after experiencing fevers for over a week and shortness of breath for 3 days. The hospital admission for Patient 1 lasted over a month and was complicated by hyperinflammatory, hypercoagulable and cardiac symptoms leading to multiorgan failure. Patient 2, also a male in his 60s, had diabetes and heart failure and was admitted following 3 days of shortness of breath and no fevers. Patient 2 did not wish to be intubated. His respiratory status continued to decline and he J o u r n a l P r e -p r o o f died shortly after admission. Fresh tissues were frozen on dry ice and stored at -80ºC. Formalinfixed paraffin-embedded tissues (FFPE) were collected and processed following routine protocols.

Bulk RNA sequencing and Gene Set Enrichment Analysis (GSEA): Bulk RNA sequencing (Illumina, San Diego, CA, USA) was performed on two technical replicates across ten tissues harvested from a single rapid autopsy (Patient 1). The raw RNAseq data was aligned to the hg38 genome using the STAR mapper (version 2.7.3a), annotated using GENCODE v35 gene annotations and counted using featureCounts (version 1.6.3) . Genes with fewer than 50 counts across all samples were excluded from the analysis, and the counts were subsequently log2transformed for differential gene expression analysis using Single-nuclei isolation and snRNAseq of OB and PFC tissues: Nuclei were isolated from frozen tissue following the recommended protocol from 10x Genomics (Pleasanton, CA, USA).

In short, lysis buffer (10 mM Tris-Hcl, 10 mM NaCl, 3 mM MgCl2 and 0.1% Nonident P40 substitute in nuclease free water) was added to frozen tissue, which was gently homogenized.

Following centrifugation, nuclei were washed in PBS + 0.04% BSA and strained to remove aggregates. Single nuclei RNA Seq was performed on these samples using the Chromium platform Figure 4B ).

Multi-scale, high resolution molecular profiling of select tissues from COVID-19 patients collected at autopsy demonstrates how these technologies can facilitate hypothesis generation, as evidenced by this and other studies leveraging the power of single-cell and spatial transcriptomic technologies 12, 13 . First, bulk RNASeq was employed to evaluate presence of viral RNA across organs from Patient 1; then infected and uninfected tissues were compared to determine key J o u r n a l P r e -p r o o f regulatory pathways associated with infection, including "blood vessel development", "cytokine production", "cell activation", and "structure and degradation". Numerous specific regulators are listed including C3AR1, a complement receptor controlling neutrophil extracellular trap (NET) formation that can lead to a pro-thrombotic state 14 , both important mechanisms implicated in COVID-19 progression 4 . C3AR1 is thus one of many examples that could serve as valuable target.

Next, snRNASeq was performed on OB and PFC tissues from Patient 1 to illustrate the feasibility and importance of mapping expression heterogeneity within cellular niches. While significant attention has been directed to ACE2, there are numerous coronavirus-associated receptors 15 . ACE2

was rarely expressed in the brain tissues analyzed here, while BSG was more widely expressed, and ANPEP showed preferential expression in vascular cell types, such as endothelial cells and 

The trinity of COVID-19: immunity, inflammation and intervention

COVID-19-associated coagulopathy: An exploration of mechanisms

Extrapulmonary manifestations of COVID-19

COVID-19: Staging of a New Disease

In situ detection of SARS-CoV-2 in lungs and airways of patients with COVID-19

Multiorgan and Renal Tropism of SARS-CoV-2

Comparison of RNA In Situ Hybridization and

Immunohistochemistry Techniques for the Detection and Localization of SARS-CoV-2 in Human Tissues

Integrating single-cell transcriptomic data across different conditions, technologies, and species

SingleCellNet: A Computational Tool to Classify Single Cell RNA-Seq Data Across Platforms and Across Species

Single-cell analysis of olfactory neurogenesis and differentiation in adult humans

A molecular single-cell lung atlas of lethal COVID-19

Regev A: A single-cell and spatial atlas of autopsy tissues reveals pathology and cellular targets of SARS-CoV-2. bioRxiv 2021

Coagulation induced by C3aR-dependent NETosis drives protumorigenic neutrophils during small intestinal tumorigenesis

A Single-Cell RNA Expression Map of Human Coronavirus Entry Factors